Fresenius | FRE - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Akzo Nobel EUR 3.19B 430M 2026-06
Alcon AG USD 1.58B 80M 2026-03
AstraZeneca USD 4.89B 2.67B 2026-06
BASF EUR 4.05B 3.74B 2026-09
Bayer EUR 4.29B 1.44B 2026-06
Beiersdorf EUR 1.28B 82M 2026-06
DaVita Healthcare Partners USD 495.63M 173.33M 2026-09
Demant DKK 1.5B 166M 2026-06
E.ON EUR 4.87B 1.83B 2026-03
Essilor EUR 1.93B 1.61B 2026-06
Fresenius EUR 1.28B 780M 2026-06
Fresenius Medical Care EUR 1.06B 177.89M 2026-06
Getinge SEK 2.05B 909M 2026-06
Givaudan CHF 603M 3M 2024-06
GlaxoSmithKline GBP 3.1B 337M 2026-06
GN Store Nord DKK 806M 59M 2026-06
GRIFOLS EUR 513M 189M 2026-06
Hikma Pharmaceutical USD 217M 19M 2025-12
Lonza CHF 719M 188M 2025-12
Merck EUR 2.74B 415M 2026-03
Novartis USD 8.87B 1.25B 2026-09
Philips EUR 1.79B 803M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
RWE EUR 6.86B 873M 2026-03
Sanofi EUR 6.35B 806M 2026-06